危重成人接受体外膜氧合后的死亡率和费用:一项基于人群的队列研究
该研究在加拿大安大略省纳入2009年10月1日至2017年3月31日接受ECMO心肺支持的692例成人患者,通过健康行政数据库链接获取结局。住院死亡率为40.0%,1年、2年、5年死亡率分别为45.1%、49.0%、57.4%。存活者中78.4%出院回家,21.2%转至持续照护机构。所有患者入院后1年中位总费用为130157加元,其中住院照护费用中位数为91192加元。作者认为危重成人ECMO住院死亡率较高,但出院后数年死亡率未明显增加,费用主要反映住院费用。
要点
- 692例接受ECMO的危重成人住院死亡率为40.0%,1年、2年、5年死亡率分别为45.1%、49.0%、57.4%。
- 从入院至启动ECMO的中位时间为2天(四分位距0-9天),平均年龄51.3岁(标准差16.0)。
- 存活者中78.4%出院回家,21.2%转至持续照护机构。
- 所有患者入院后1年中位总费用为130157加元(四分位距58645-240763加元),其中住院照护费用中位数91192加元(四分位距38507-184728加元)。
- 作者认为危重成人ECMO住院死亡率较高,但出院后数年死亡率未明显增加,费用主要反映住院费用而非出院后费用。
适用人群与场景
- 加拿大安大略省2009年10月1日至2017年3月31日接受ECMO心肺支持的成人患者(≥18岁),基于人群的队列。
研究设计与关键结果
- 基于人群的队列研究,纳入692例接受ECMO心肺支持的成人患者,平均年龄51.3岁(标准差16.0),从入院至启动ECMO的中位时间为2天(四分位距0-9天)。
- 住院死亡率为40.0%;1年、2年、5年死亡率分别为45.1%、49.0%、57.4%。
- 存活者中78.4%出院回家,21.2%转至持续照护机构。
- 所有患者入院后1年中位总费用为130157加元(四分位距58645-240763加元),其中住院照护费用中位数为91192加元(四分位距38507-184728加元)。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为危重成人接受ECMO进行高级心肺支持时住院死亡率较高,但出院后数年死亡率未明显增加,存活者更可能出院回家而非转至持续照护机构,中位费用较高但主要反映住院费用而非出院后费用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Extracorporeal membrane oxygenation (ECMO) is used as temporary cardiorespiratory support in critically ill patients. Little is known about population-level short- and long-term outcomes following ECMO, including healthcare use and health system cost across a wide range of sectors.
METHODS: Population-based cohort study in Ontario, Canada (October 1, 2009-March 31, 2017) of adult patients (≥ 18 years) receiving ECMO for cardiorespiratory support. We captured outcomes through linkage to health administrative databases. Primary outcome was mortality during hospitalization, as well as at 7 days, 30 days, 1 year, 2 years, and 5 years following ECMO initiation. We analyzed health system costs (in Canadian dollars) in the 1 year following the date of the index admission.
RESULTS: A total of 692 patients were included. Mean (standard deviation [SD]) age was 51.3 (16.0) years. Median (interquartile range [IQR]) time to ECMO initiation from date of admission was 2 (0-9) days. In-hospital mortality was 40.0%. Mortality at 1 year, 2 years, and 5 years was 45.1%, 49.0%, and 57.4%, respectively. Among survivors, 78.4% were discharged home, while 21.2% were discharged to continuing care. Median (IQR) total costs in the 1 year following admission among all patients were Canadian $130,157 (Canadian $58,645-Canadian $240,763), of which Canadian $91,192 (Canadian $38,507-Canadian $184,728) were attributed to inpatient care.
CONCLUSIONS: Hospital mortality among critically ill adults receiving ECMO for advanced cardiopulmonary support is relatively high, but does not markedly increase in the years following discharge. Survivors are more likely to be discharged home than to continuing care. Median costs are high, but largely reflect inpatient hospital costs, and not costs incurred following discharge.
参考来源
- Fernando SM, Qureshi D, Tanuseputro P, et al. Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study. Intensive Care Med. 2019. PMID: 31529353. doi:10.1007/s00134-019-05766-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。